Since 1996 WHN is the second oldest medical website on the net, second only to the American Medical Association, servicing over 35,000 physicians and scientists worldwide.
Non-Profit Trusted Source of Non-Commercial Health Information
According to a press announcement, the US FDA has approved Opdivo (nivolumab), in combination with certain types of chemotherapy, for the initial treatment of patients with advanced or metastatic gastric cancer, gastroesophageal junction cancer and esophageal adenocarcinoma. This is the first FDA-approved immunotherapy for the first-line treatment of gastric cancer. “Today’s approval is the first …
The US FDA has made the first approval in 16 years for the treatment of mesothelioma, which is a type of cancer that is caused by inhaling asbestos fibres, according to the recent new release. Opdivo (nivolumab) in combination with Yervoy (ipilimumab) was recently approved by the US FDA for the first-line treatment of adults …